- Title
- Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials
- Creators
- U Platzbecker - University Hospital LeipzigP Fenaux - Hôpital Saint-LouisL Adès - Hôpital Saint-LouisA GiagounidisV Santini - Azienda Ospedaliero-Universitaria CareggiA A van de Loosdrecht - Amsterdam UMC Location VUmcD Bowen - Leeds Teaching Hospitals NHS TrustT de Witte - Radboud University NijmegenG Garcia-Manero - The University of Texas MD Anderson Cancer CenterE Hellström-Lindberg - Karolinska InstitutetU Germing - European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany;R Stauder - Innsbruck Medical UniversityL Malcovati - University of PaviaMikkael A Sekeres - Cleveland ClinicDavid P Steensma - Dana-Farber Cancer InstituteS Gloaguen - European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
- Publication Details
- Blood, Vol.133(10), pp.1020-1030
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 30404811
- PMCID
- PMC7042664
- Record Identifier
- 991031757877102976
Journal article
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials
Blood, Vol.133(10), pp.1020-1030
2019-03-07
PMCID: PMC7042664
PMID: 30404811
Metrics
1 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.103 Blood Disorders
- 1.103.155 Acute Myeloid Leukemia
- Web Of Science research areas
- Hematology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites